This story originally ran on Aug. 4.

Satoris this week said that it will distribute Rules-Based Medicine's panel of 189 protein biomarkers for neurology research.

RBM launched the service-based biomarker panel, called DiscoveryMAP, in June. The same month, Satoris launched three neurology biomarker panels of its own, one for differentiating patients with Alzheimer's disease from other forms of dementia, and two panels for plasma proteins associated with neurodegeneration and neuroinflammation

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.